First and only AFib ablation products to receive approval for use in a workflow without fluoroscopy from the U.S. Food and Drug Administration "The label change approved by the FDA underscores that ...
Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety an
Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL ® SMARTTOUCH ™ Catheter THERMOCOOL ® SMARTTOUCH ™ Catheter and ...
Webster has developed the Carto 3 mapping and navigation system that provides 3D imaging Irvine-based Biosense Webster, a unit of Johnson & Johnson, said it’s developed a way to help patients and ...
The U.S. Food and Drug Administration (FDA) today approved an innovative combination of technologies that will enhance a doctors' ability to treat patients with abnormal heart rhythms (cardiac ...
Completes First Atrial Fibrillation Ablation Case in the United States Using The THERMOCOOL ® SMARTTOUCH ™ Contact Force Sensing Catheter & Software Module DIAMOND BAR, Calif.--(BUSINESS WIRE)-- ...
Diamond Bar, CA – October 12, 2005 – Biosense Webster, Inc. today announced that the company has received clearance by the U.S. Food and Drug Administration (FDA) for devices that aid ...
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced that several products in its market-leading cardiac ablation portfolio have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results